2014
DOI: 10.1016/j.joca.2014.04.019
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological effects of novel cross-linked hyaluronate, Gel-200, in experimental animal models of osteoarthritis and human cell lines

Abstract: A single-dose IA injection of Gel-200 exerts chondroprotective and anti-inflammatory effects in the experimental OA model, and long-lasting analgesia in the joint pain model, suggesting the beneficial multimodal function of Gel-200 against symptomatic OA patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0
4

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(21 citation statements)
references
References 25 publications
0
17
0
4
Order By: Relevance
“…Sixty-seven of the included articles described chondroprotective effects of IA-HA treatment [ 9 , 12 , 16 80 ]. IA-HA has been shown to reduce chondrocyte apoptosis, while increasing chondrocyte proliferation [ 19 , 20 ].…”
Section: Resultsmentioning
confidence: 99%
“…Sixty-seven of the included articles described chondroprotective effects of IA-HA treatment [ 9 , 12 , 16 80 ]. IA-HA has been shown to reduce chondrocyte apoptosis, while increasing chondrocyte proliferation [ 19 , 20 ].…”
Section: Resultsmentioning
confidence: 99%
“…[289,290] A comprehensive review [291] of MED-LINE, EMBASE, and PUBMED databases uncovered 2782 articles on HAs used in OA treatment. These were i) chondroprotection, [135,242,285,289,[292][293][294][295][296][297][298][299][300] ii) promotion of PG/GAG biosynthesis, [287,295,297,[301][302][303] iii) anti-inflammatory effects, [285,290,293,295,303,304] iv) mechanical effects, [296,299,302,305] v) effects on subchondral bone, [294,306] and vi) analgesic properties. These were i) chondroprotection, [135,242,285,289,[292][293][294][295][296][297][298][299][300] ii) promotion of PG/GAG ...…”
Section: The Efficacy Of High or Low Molecular Weight Ha In Oa Therapmentioning
confidence: 99%
“…Of these, six major categories were identified to describe the beneficial effects afforded by treatment with high molecular weight HA preparations. [300,307] The development of high molecular weight HAs such as Hylan G-F and Durolane represent significant technological advances in terms of their in vitro rheological properties which translate in vivo into improved visco-elastic, chondroprotective weight bearing properties and pain alleviation in the treatment of OA. [300,307] The development of high molecular weight HAs such as Hylan G-F and Durolane represent significant technological advances in terms of their in vitro rheological properties which translate in vivo into improved visco-elastic, chondroprotective weight bearing properties and pain alleviation in the treatment of OA.…”
Section: The Efficacy Of High or Low Molecular Weight Ha In Oa Therapmentioning
confidence: 99%
“…The pathogenesis of knee osteoarthritis is not completely known yet; however, the key feature in OA has been referred to as the unbalanced differentiation and proliferation of chondrocytes. In addition to this, there are some other factors that play a role in development of OA, including cross-linked hyaluronates, GDF-5, C-reactive proteins (CRP), Gel-200, and erythrocyte sedimentation rate (ESR) (8).…”
Section: Introductionmentioning
confidence: 99%